Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1940 1
1941 1
1954 1
1958 1
1961 1
1962 1
1964 2
1967 2
1971 2
1972 2
1973 4
1975 1
1976 1
1977 1
1978 1
1979 1
1981 3
1982 6
1983 2
1984 2
1985 3
1987 3
1988 4
1989 4
1990 2
1991 2
1993 2
1994 4
1995 3
1996 3
1997 2
1998 2
1999 3
2000 6
2001 4
2002 4
2003 9
2004 2
2005 3
2006 4
2007 6
2008 3
2009 7
2010 11
2011 6
2012 8
2013 4
2014 11
2015 15
2016 15
2017 16
2018 15
2019 23
2020 20
2021 29
2022 38
2023 27
2024 16

Text availability

Article attribute

Article type

Publication date

Search Results

340 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Alanis-Reyes
Page 1
Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations.
Russell NH, Wilhelm-Benartzi C, Othman J, Dillon R, Knapper S, Batten LM, Canham J, Hinson EL, Betteridge S, Overgaard UM, Gilkes A, Potter N, Mehta P, Kottaridis P, Cavenagh J, Hemmaway C, Arnold C, Freeman SD, Dennis M; PORTEC Study Group. Russell NH, et al. J Clin Oncol. 2024 Apr 1;42(10):1158-1168. doi: 10.1200/JCO.23.00943. Epub 2024 Jan 12. J Clin Oncol. 2024. PMID: 38215358 Clinical Trial.
340 results